NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/11/2025
Back to search
Official data from USPTO
SYMBIOZE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
12/12/2025
Trademark type
Word
Nice classes
10
Filing date
04/12/2022
Registration date
02/27/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/27/2024
Last transaction
12/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
WERT,KARL ANTHONY
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
N. V. (pessoa física)
Representatives
Andy I. Corea Murtha Cullina LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Injection devices for pharmaceutical preparations; injection pumps for pharmaceutical purposes; portable medical fluid injectors; medical and therapeutic apparatus and instruments for medication self-injection being medical infusion and injection devices for administering drugs; medical apparatus for intravenousintradermalintramuscular or subcutaneous infusiontissue infusioninjection and accessories thereof being patch-worn on-body injectora syringe for medical purposes and consisting of disposable or reusable medical apparatus for intravenousintradermalintramuscular or subcutaneous medical infusionmedical tissue infusionmedical injection intended to cooperate with a medical pumpall the foregoing being medical infusion and injection devices for administering drugs; medical and therapeutic apparatus and instruments for medication self-injection being medical infusion and injection devices for administering drugs; medical adhesive apparatus for intravenousintradermalintramuscular or subcutaneous injection or infusion and replacement parts thereof being patch-worn on-body injectora syringe for medical purposes and consisting of disposable or reusable medical apparatus for intravenousintradermalintramuscular or subcutaneous medical infusionmedical tissue infusionmedical injection intended to cooperate with a medical pumpall the foregoing being medical infusion and injection devices for administering drugs; medical pumps for intravenousintramuscularintradermal or subcutaneous injection or infusion and replacement parts thereofreusable or disposable medical pump intended to cooperate with medical apparatus for intravenousintradermalintramuscular or subcutaneous medical infusionmedical tissue infusionmedical injectionall the foregoing being medical infusion or injection devices and replacement parts thereof for administering drugs; patch pumps being adhesive infusion pumps for delivering measured injection of pharmaceutical preparations into the bloodstream over time and replacement parts thereofreusable or disposable medical pump intended to cooperate with medical apparatus for intravenousintradermalintramuscular or subcutaneous medical infusionmedical tissue infusionmedical injection
Publications
History of USPTO decisions and trademark events.
33 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/27/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/08/2024
FIMP
FINAL DISPOSITION PROCESSED
07/08/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/28/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/27/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2023
PUBO
PUBLISHED FOR OPPOSITION
12/12/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/11/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/27/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/22/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/22/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/08/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
11/03/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/03/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
11/03/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/21/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/21/2023
RFNT
REFUSAL PROCESSED BY IB
04/19/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/30/2023
RFRR
REFUSAL PROCESSED BY MPU
03/30/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/08/2023
CNRT
NON-FINAL ACTION WRITTEN
02/07/2023
DOCK
ASSIGNED TO EXAMINER
01/30/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/02/2022
Continuous trademark protection
Get notified about every new filing that threatens SYMBIOZE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.